Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)
- Status
- COMPLETED
- Phase
- PHASE3
Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2